Joost W Geenen

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To assess the resource use and associated costs of treating patients with metastatic prostate cancer with a focus on skeletal-related events (SREs). METHODS We performed a bottom-up cost of illness study in The Netherlands. RESULTS A total of 136 patients were studied. The mean total costs were €17,931 per patient. SREs that required hospitalization(More)
AIM To assess the required characteristics (cost, sensitivity and specificity) of a pharmacogenomic test for being a cost-effective prevention of angiotensin-converting enzyme inhibitors induced angioedema. Furthermore, we assessed the influence of only testing high-risk populations. MATERIALS & METHODS A decision tree was used. RESULTS With a(More)
  • 1